We are live on
!
Find out more
PCP
Pacific Capital Partners Portfolio holdings
AUM
$116M
1-Year Est. Return
24.59%
This Fund
S&P 500
This Quarter
Est. Return
-1.6%
1 Year Est. Return
+24.59%
3 Year Est. Return
+49.79%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$151M
AUM Growth
-$1.76M
(-1.2%)
Cap. Flow
+$2.98M
Cap. Flow
% of AUM
1.97%
Top 10 Holdings %
Top 10 Hldgs %
48.52%
Holding
63
New
5
Increased
15
Reduced
8
Closed
5
Avg Time Held
2.6
quarters
Top 10 Avg Time Held
2.7
quarters
Top 20 Avg Time Held
2.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Avantor
AVTR
|
+$2.41M |
| 2 |
Arcosa
ACA
|
+$2.29M |
| 3 |
Standard BioTools
LAB
|
+$1.83M |
| 4 |
PayPal
PYPL
|
+$1.75M |
| 5 |
EPAM Systems
EPAM
|
+$1.07M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Woodward
WWD
|
+$3.83M |
| 2 |
KKR & Co
KKR
|
+$2.01M |
| 3 |
NextEra Energy
NEE
|
+$1.92M |
| 4 |
Republic Services
RSG
|
+$1.42M |
| 5 |
Vestis
VSTS
|
+$964K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 50.01% |
| 2 | Industrials | 26% |
| 3 | Financials | 9.58% |
| 4 | Materials | 5.34% |
| 5 | Consumer Discretionary | 4.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
51
HCA Healthcare
HCA
$94.2B
| $802K | 0.53% |
2,495
| – | – |
2023 Q3
3 quarters
|
|
52
lululemon athletica
LULU
$10.2B
| $644K | 0.43% |
2,156
+451
| +26% | +$151K |
2023 Q3
3 quarters
|
|
53
Ecolab
ECL
$78B
| $631K | 0.42% |
2,653
-862
| -25% | -$199K |
2023 Q3
3 quarters
|
|
54
Tandem Diabetes Care
TNDM
$1.14B
| $616K | 0.41% |
15,282
| – | – |
2023 Q3
3 quarters
|
|
55
Nike
NKE
$49.9B
| $601K | 0.4% |
7,972
| – | – |
2023 Q3
3 quarters
|
|
|
AMED
56
DELISTED
Amedisys
AMED
| $593K | 0.39% |
6,457
| – | – |
2023 Q3
3 quarters
|
|
57
CVS Health
CVS
$111B
| $559K | 0.37% |
9,471
| – | – |
2023 Q3
3 quarters
|
|
58
Align Technology
ALGN
$9.92B
| $444K | 0.29% |
1,839
| – | – |
2023 Q3
3 quarters
|
|
59
Blackrock
BLK
$166B
| – | – |
-365
| Closed | -$304K | – |
|
60
Guardant Health
GH
$24.9B
| – | – |
-10,329
| Closed | -$213K | – |
|
|
61
KKR & Co
KKR
$80.8B
| – | – |
-20,000
| Closed | -$2.01M | – |
|
|
62
NextEra Energy
NEE
$159B
| – | – |
-30,000
| Closed | -$1.92M | – |
|
|
63
Vestis
VSTS
$1.86B
| – | – |
-50,000
| Closed | -$964K | – |
|
Similar funds
VWA
JBC
IIWM
JBI
BWM
SAM
ACA
VFM
Pacific Capital Partners's Q2 2024 Portfolio in Review
As of Q2 2024, Pacific Capital Partners held 63 positions worth $151M, down 1.2% from $153M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Pacific Capital Partners's Q2 2024 filing shows 5 new, 15 increased, 8 reduced and 5 closed positions. Its largest new stake was Arcosa: 27,500 shares worth $2.29M. The largest sale was Woodward, an estimated $3.83M.
By sector, the portfolio is most concentrated in Healthcare at 50% of assets, up from 47% a quarter earlier, followed by Industrials and Financials.
- Pacific Capital Partners's largest Q2 2024 buy was Arcosa: 27,500 shares worth $2.29M.
- Pacific Capital Partners added most to Avantor in Q2 2024, an estimated $2.41M increase.
- Pacific Capital Partners's biggest Q2 2024 reduction was Woodward, cutting an estimated $3.83M.
- Pacific Capital Partners fully exited KKR & Co in Q2 2024, selling an estimated $2.01M.
- Pacific Capital Partners's ten largest holdings make up 49% of its $151M portfolio in Q2 2024.
- Pacific Capital Partners opened 5 new positions and closed 5 in Q2 2024.
- Pacific Capital Partners's portfolio value fell 1.2% quarter-over-quarter to $151M.
Based on Pacific Capital Partners's 13F filing for Q2 2024, filed 8 May 2025.